Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?

Jakob Wested, Timo Minssen, Esther Van Zimmeren

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
OriginalsprogEngelsk
TidsskriftLife Sciences Intellectual Property Review (LSIPR)
Udgave nummer13/7 2018
Antal sider6
StatusUdgivet - 13 jul. 2018

Emneord

  • Det Juridiske Fakultet

Adgang til dokumentet

  • 1 Foredrag og mundtlige bidrag

Citationsformater